Subscribe to RSS - ResMed

ResMed

ResMed documents family’s travel with vents

 - 
08/31/2016

SAN DIEGO – ResMed has produced a documentary film featuring a family that decides to continue to travel and enjoy the outdoors despite having two children living with Duchenne muscular dystrophy (DMD).

ResMed: ‘We’re committed to compliance’

 - 
08/26/2016

SAN DIEGO – Will ResMed become the second major manufacturer to get a slap on the wrist from the government for its resupply program?

In brief: Drive explains sale, ResMed and F&P trade lawsuits

 - 
08/19/2016

PORT WASHINGTON, N.Y. – Drive Medical has sent a letter to its customers in response to reports that private equity firm Clayton, Dubilier & Rice is close to buying the company.

ResMed under investigation

 - 
08/19/2016

SAN DIEGO – ResMed in July received a federal administrative subpoena from the Office of Inspector General requesting documents and other information related to its patient resupply software.

ResMed fires back at Fisher & Paykel

 - 
08/18/2016

SAN DIEGO – ResMed has filed patent infringement actions against Fisher & Paykel Healthcare in U.S., German and New Zealand courts, as well as the U.S. International Trade Commission.

ResMed launches myAir app

 - 
08/18/2016

SAN DIEGO – iPhone users can now download ResMed’s myAir, a program for CPAP users to track their own sleep apnea treatment, from the Apple App Store.

F&P sues ResMed

 - 
08/16/2016

AUCKLAND, New Zealand – Fisher & Paykel Healthcare has filed patent infringement proceedings against ResMed in the U.S. District Court for the Central District of California.

ResMed looks for growth in resupplies

‘I think there is a lot of runway (in that business),’ says top exec
 - 
08/05/2016

SAN DIEGO – ResMed invested $1 billion in acquisitions in fiscal year 2016. Now, the company is “laser focused” on getting a return on its investment, says CEO Mick Farrell.

Earnings: Invacare reports losses, ResMed reports growth

 - 
07/29/2016

ELYRIA, Ohio – Invacare posted second quarter losses today, but remains excited as it continues to shift from a general DME company to one more focused on clinically complex care, says Matthew Monaghan.

ResMed on growth ‘trajectory’

 - 
07/29/2016

SAN DIEGO – ResMed ended its fiscal year 2016 with double-digit growth and is on a “trajectory to be the world’s leading tech-driven medical device company,” say company execs.

Pages